Schisandrin B Alleviates LPS Induced Mitochondrial Damage in C28I2 Cells

Overview

Journal J Membr Biol

Date 2024 Jan 29

PMID 38285126

Authors

Fei Hu

Wenjie Hu

Hongming Xu

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis is a common joint disease characterized by damage to the joint cartilage that occurs throughout the entire joint tissue. This damage primarily manifests as pain in the affected area. In clinical practice, medication is commonly used to relieve pain, but the treatment's effectiveness is poor and recurrent attacks are likely. Schisandrin B is the most abundant biphenylcyclohexene lignan found in the traditional Chinese medicine Schisandra chinensis, and it possesses various pharmacological effects. This study aims to investigate the protective effect of Schisandrin B on mitochondrial damage in osteoarthritis (C28I2 cells) under an inflammatory environment induced by LPS. Cell proliferation and activity, scratch tests, and LDH release tests are utilized to assess cell growth and migration ability. The immunofluorescence assay was used to detect the expression levels of proliferation and apoptosis proteins. The Western Blot assay was used to detect the expression levels of mitochondrial fusion and division proteins. The JC-1 assay was used to detect changes in mitochondrial membrane potential. The mitochondrial fluorescence probe assay was used to detect mitochondrial activity. Through research, it was found that Schisandrin B promotes the proliferation, growth, and migration of C28I2 cells, reduces apoptosis of C28I2 cells, balances mitochondrial fusion and division, stabilizes mitochondrial membrane potential, and promotes mitochondrial activity in an LPS induced inflammatory environment.

References

Abdel-Aziz M, Ahmed H, El-Nekeety A, Abdel-Wahhab M . Osteoarthritis complications and the recent therapeutic approaches. Inflammopharmacology. 2021; 29(6):1653-1667. DOI: 10.1007/s10787-021-00888-7. View

Abramoff B, Caldera F . Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020; 104(2):293-311. DOI: 10.1016/j.mcna.2019.10.007. View

Adebayo M, Singh S, Singh A, Dasgupta S . Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. FASEB J. 2021; 35(6):e21620. PMC: 8415099. DOI: 10.1096/fj.202100067R. View

Andrieux P, Chevillard C, Cunha-Neto E, Nunes J . Mitochondria as a Cellular Hub in Infection and Inflammation. Int J Mol Sci. 2021; 22(21). PMC: 8583510. DOI: 10.3390/ijms222111338. View

Annesley S, Fisher P . Mitochondria in Health and Disease. Cells. 2019; 8(7). PMC: 6678092. DOI: 10.3390/cells8070680. View

Averbeck D, Rodriguez-Lafrasse C . Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts. Int J Mol Sci. 2021; 22(20). PMC: 8541263. DOI: 10.3390/ijms222011047. View

Bader V, Winklhofer K . Mitochondria at the interface between neurodegeneration and neuroinflammation. Semin Cell Dev Biol. 2019; 99:163-171. DOI: 10.1016/j.semcdb.2019.05.028. View

Chan D . Mitochondrial Dynamics and Its Involvement in Disease. Annu Rev Pathol. 2019; 15:235-259. DOI: 10.1146/annurev-pathmechdis-012419-032711. View

Chen X, Xiao Z, Jiang Z, Jiang Y, Li W, Wang M . Schisandrin B Attenuates Airway Inflammation and Airway Remodeling in Asthma by Inhibiting NLRP3 Inflammasome Activation and Reducing Pyroptosis. Inflammation. 2021; 44(6):2217-2231. DOI: 10.1007/s10753-021-01494-z. View

10.

Cho Y, Jeong S, Kim H, Kang D, Lee J, Kang S . Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp Mol Med. 2021; 53(11):1689-1696. PMC: 8640059. DOI: 10.1038/s12276-021-00710-y. View

11.

Colletti A, Cicero A . Nutraceutical Approach to Chronic Osteoarthritis: From Molecular Research to Clinical Evidence. Int J Mol Sci. 2021; 22(23). PMC: 8658017. DOI: 10.3390/ijms222312920. View

12.

Coryell P, Diekman B, Loeser R . Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2020; 17(1):47-57. PMC: 8035495. DOI: 10.1038/s41584-020-00533-7. View

13.

Ding M, Shu P, Gao S, Wang F, Gao Y, Chen Y . Schisandrin B protects human keratinocyte-derived HaCaT cells from tert-butyl hydroperoxide-induced oxidative damage through activating the Nrf2 signaling pathway. Int J Mol Med. 2018; 42(6):3571-3581. DOI: 10.3892/ijmm.2018.3901. View

14.

Hawker G, King L . The Burden of Osteoarthritis in Older Adults. Clin Geriatr Med. 2022; 38(2):181-192. DOI: 10.1016/j.cger.2021.11.005. View

15.

Hu X, Guo C, Hou J, Feng J, Zhang X, Xiong F . Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer's Disease: Stereochemistry and Biological Activity. ACS Chem Neurosci. 2018; 10(2):996-1007. DOI: 10.1021/acschemneuro.8b00252. View

16.

Hunter D, Bierma-Zeinstra S . Osteoarthritis. Lancet. 2019; 393(10182):1745-1759. DOI: 10.1016/S0140-6736(19)30417-9. View

17.

Li Y, Liu H, Xue C, Xing X, Dong S, Wang L . The synergistic anti-tumor effect of schisandrin B and apatinib. J Asian Nat Prod Res. 2019; 22(9):839-849. DOI: 10.1080/10286020.2019.1645131. View

18.

Li B, Guan G, Mei L, Jiao K, Li H . Pathological mechanism of chondrocytes and the surrounding environment during osteoarthritis of temporomandibular joint. J Cell Mol Med. 2021; 25(11):4902-4911. PMC: 8178251. DOI: 10.1111/jcmm.16514. View

19.

Luo Y, Ma J, Lu W . The Significance of Mitochondrial Dysfunction in Cancer. Int J Mol Sci. 2020; 21(16). PMC: 7460667. DOI: 10.3390/ijms21165598. View

20.

Molnar V, Matisic V, Kodvanj I, Bjelica R, Jelec Z, Hudetz D . Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. Int J Mol Sci. 2021; 22(17). PMC: 8431625. DOI: 10.3390/ijms22179208. View